Inflammatory markers (C-reactive protein (CRP) and procalcitonin) and more nuanced indicators like the neutrophil-to-lymphocyte ratio (NLR) and systemic immune inflammation index (SII) can offer a window into infection severity in COVID-19 patients [19,20]. This evidence concerns the gene CRP and infection.